ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981

In Brief: NCI Thinks Puerto Rico Should Have Comprehensive Center; President Says He Won’t Oppose NIH Budget Increases

April 26, 1974

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

Impetus to Proceed with a March Came From Talk Show

October 31, 1997

“We’d Ban Cigarettes’ If Nicotine Were a Drug, FDA Commissioners Says

February 14, 1992

In Brief: Lucius Sinks New Cancer Centers Branch Chief; Mary Sears, One Of ASCO Founders, to Retire

May 11, 1984